GlassScriptPhysician profile
Ravi D Raju
NPI 1831189562
$1,753.42
in general payments reported to CMS, 2019-2025
25 companies · $151 in 2025
The $151 reported for 2025 was less than what a typical Obstetrics & Gynecology provider received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $116 · 2020: $186 · 2021: $439 · 2022: $471 · 2023: $168 · 2024: $222 · 2025: $151.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $535 · Education: $6.55.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $535.42 |
| Education | $6.55 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $580.15 | 2019-2023 | |
| Medical Device Business Services, INC. | $205.59 | 2021-2025 | Vistaseal |
| Astellas Pharma US INC | $190.31 | 2024 | Veozah |
| Coopersurgical, INC. | $112.71 | 2020-2025 | Paragard T 380a |
| Davol INC. | $91.40 | 2022 | |
| Amgen INC. | $62.53 | 2021-2022 | |
| Exeltis, USA INC. | $56.63 | 2021-2022 | |
| Organon LLC | $43.40 | 2021-2023 | Nexplanon |
| Mayne Pharma Commercial LLC | $41.56 | 2021-2022 | |
| Hologic Sales and Service, LLC | $39.21 | 2019-2025 | Novasure |
| Merck Sharp & Dohme LLC | $38.40 | 2019-2020 | |
| Medtronic, INC. | $36.05 | 2022 | |
| Bayer Healthcare Pharmaceuticals INC. | $28.80 | 2022 | |
| Axonics, INC. | $28.26 | 2023 | Bulkamid, Axonics |
| Therapeuticsmd, INC. | $25.38 | 2019-2022 |
Show all 25 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Sumitomo Pharma America, INC. | $24.69 | 2024 | Myfembree |
| Pfizer INC. | $24.54 | 2021-2023 | |
| Meditrina | $21.21 | 2023 | |
| Channel Medsystems, INC. | $19.15 | 2023 | |
| Daiichi Sankyo INC. | $18.11 | 2022 | |
| Dysis Medical, INC. | $16.38 | 2022 | |
| Amag Pharmaceuticals, INC. | $15.16 | 2019 | |
| Mylan Pharmaceuticals INC. | $14.60 | 2022 | |
| Avion Pharmaceuticals | $11.83 | 2021 | |
| Aspira Women'S Health INC | $7.37 | 2024 | Ova1 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ravi Raju listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.